论文部分内容阅读
给复发一缓解型多发硬化（Relapsing-RemittinpMutipleSclerosisRRMS）病人隔天一次皮下注射重组pl卜干扰素（YIFN－slb），在治疗后通过敏感性强的磷共振（MRD监测证实MS病灶较治疗前明显缩小或消失，从而达到降低该病的活动性及恶化率的目的。采用ELISA双抗体夹心法检测RRMS
To patients with relapsing-remitting mutiple sclerosis (RRMS), subcutaneous injection of recombinant interferon-gamma (IFN-slb) subcutaneously once a day followed by high sensitivity phosphorus resonance (MRD monitoring confirmed MS lesions significantly reduced compared with before treatment Or disappear, so as to achieve the goal of reducing the activity and the rate of exacerbation.Using ELISA double antibody sandwich method to detect RRMS